Is the New Classification of Neuroendocrine Pancreatic Tumors of Clinical Help? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-11

AUTHORS

Martin Schindl, Klaus Kaczirek, Klaus Kaserer, Bruno Niederle

ABSTRACT

A new concept of classifying neuroendocrine pancreatic tumors based on clinicopathologic patterns was summarized recently. To evaluate the clinical reliability and prognostic specificity of this classification system, 100 neuroendocrine pancreatic tumors were retrospectively categorized as “benign,”“uncertain,” and “malignant” based on tumor risk factors (size, local invasion and angioinvasion, cell atypia, metastases) and were followed for disease recurrence and progression. Altogether, 71 functioning tumors (insulinoma, gastrinoma, glucagonoma, enterochromaffin-like (ECL)oma, somatostatinoma) and 29 nonfunctioning neuroendocrine pancreatic tumors (NETs) were studied. NETs had an increased risk of malignancy (p < 0.05). Tumor size, gross invasion, and metastases correlated significantly with tumor behavior and allowed us to distinguish between “benign” and “malignant” tumors. About 89% of the tumors ≤ 20 mm were “benign,” whereas 71% > 20 mm were “malignant” (p < 0.05). In patients with “benign” and “uncertain” neuroendocrine pancreatic tumors, neither recurrence nor progression of disease was seen. About 41% of the patients with “malignant” tumors died of the disease. The 5-year estimated cumulative survival of those with “benign” and “uncertain” tumors was 100% and 52 ± 10% for those with “malignant” tumors (p < 0.05). Histomorphologic details classifying the behavior of an “uncertain” tumor are known only after initial treatment and definitive histopathologic investigation. Thus this information is of limited clinical help for treatment strategies. More... »

PAGES

1312-1318

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002680010217

DOI

http://dx.doi.org/10.1007/s002680010217

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034826001

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11038199


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biopsy, Needle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Evaluation Studies as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuroendocrine Tumors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Function Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schindl", 
        "givenName": "Martin", 
        "id": "sg:person.0603017413.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603017413.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaczirek", 
        "givenName": "Klaus", 
        "id": "sg:person.01163404744.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163404744.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Clinical Pathology, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Institute of Clinical Pathology, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaserer", 
        "givenName": "Klaus", 
        "id": "sg:person.01046040764.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046040764.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Niederle", 
        "givenName": "Bruno", 
        "id": "sg:person.014465706030.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014465706030.17"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s001090050233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014446718", 
          "https://doi.org/10.1007/s001090050233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690494", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039860600", 
          "https://doi.org/10.1038/sj.bjc.6690494"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-11", 
    "datePublishedReg": "2000-11-01", 
    "description": "A new concept of classifying neuroendocrine pancreatic tumors based on clinicopathologic patterns was summarized recently. To evaluate the clinical reliability and prognostic specificity of this classification system, 100 neuroendocrine pancreatic tumors were retrospectively categorized as \u201cbenign,\u201d\u201cuncertain,\u201d and \u201cmalignant\u201d based on tumor risk factors (size, local invasion and angioinvasion, cell atypia, metastases) and were followed for disease recurrence and progression. Altogether, 71 functioning tumors (insulinoma, gastrinoma, glucagonoma, enterochromaffin-like (ECL)oma, somatostatinoma) and 29 nonfunctioning neuroendocrine pancreatic tumors (NETs) were studied. NETs had an increased risk of malignancy (p < 0.05). Tumor size, gross invasion, and metastases correlated significantly with tumor behavior and allowed us to distinguish between \u201cbenign\u201d and \u201cmalignant\u201d tumors. About 89% of the tumors \u2264 20 mm were \u201cbenign,\u201d whereas 71% > 20 mm were \u201cmalignant\u201d (p < 0.05). In patients with \u201cbenign\u201d and \u201cuncertain\u201d neuroendocrine pancreatic tumors, neither recurrence nor progression of disease was seen. About 41% of the patients with \u201cmalignant\u201d tumors died of the disease. The 5-year estimated cumulative survival of those with \u201cbenign\u201d and \u201cuncertain\u201d tumors was 100% and 52 \u00b1 10% for those with \u201cmalignant\u201d tumors (p < 0.05). Histomorphologic details classifying the behavior of an \u201cuncertain\u201d tumor are known only after initial treatment and definitive histopathologic investigation. Thus this information is of limited clinical help for treatment strategies.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s002680010217", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1086446", 
        "issn": [
          "0364-2313", 
          "1432-2323"
        ], 
        "name": "World Journal of Surgery", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "24"
      }
    ], 
    "keywords": [
      "neuroendocrine pancreatic tumors", 
      "pancreatic tumors", 
      "clinical help", 
      "tumor risk factors", 
      "risk of malignancy", 
      "progression of disease", 
      "prognostic specificity", 
      "disease recurrence", 
      "initial treatment", 
      "clinicopathologic patterns", 
      "tumor size", 
      "cumulative survival", 
      "histopathologic investigation", 
      "gross invasion", 
      "risk factors", 
      "treatment strategies", 
      "tumor behavior", 
      "tumors", 
      "clinical reliability", 
      "patients", 
      "recurrence", 
      "disease", 
      "progression", 
      "new classification", 
      "classification system", 
      "histomorphologic detail", 
      "malignancy", 
      "metastasis", 
      "survival", 
      "treatment", 
      "risk", 
      "invasion", 
      "specificity", 
      "factors", 
      "patterns", 
      "strategies", 
      "classification", 
      "investigation", 
      "help", 
      "information", 
      "new concept", 
      "size", 
      "behavior", 
      "reliability", 
      "system", 
      "detail", 
      "concept", 
      "NETs", 
      "definitive histopathologic investigation", 
      "limited clinical help"
    ], 
    "name": "Is the New Classification of Neuroendocrine Pancreatic Tumors of Clinical Help?", 
    "pagination": "1312-1318", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034826001"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002680010217"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11038199"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002680010217", 
      "https://app.dimensions.ai/details/publication/pub.1034826001"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_315.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s002680010217"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002680010217'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002680010217'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002680010217'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002680010217'


 

This table displays all metadata directly associated to this object as RDF triples.

231 TRIPLES      22 PREDICATES      101 URIs      91 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002680010217 schema:about N020871f77f4c47469b0a31f6d333e0af
2 N0fed3f9ef25c4fc8a30a0c23a1ed7c8b
3 N1fd455226c99403488c06549efc75e81
4 N24825158f98f45a191bec1017f867bc2
5 N289fbca686b8463db3d622b6587d6f7b
6 N2c0dc2c07ad64ea98d3a6a85b3b2de3d
7 N315f73f1012f42ceaf69f8311e187a97
8 N36402be6fe2544f0981f6636af20fbe8
9 N445c6bdc136747a48ce0e87b7817b852
10 N5a6078a30f6d4978aad489e4987b9e80
11 N5de8bcee78b847468f58633362be2e62
12 N6d73bd534ea64c36be331db2089ef97e
13 N908c353cefd44d70a6dfdbb59b16b64e
14 N9f721c435f9d4a098f72618dff93404e
15 Na2df85fda9634445aac5079398577463
16 Na4e7003b24b64f42a7a7447353833785
17 Nae8e8a308b744f5dbbd6672573002802
18 Nafa6ce549a804f4daf5458a8b02ae712
19 Nbbf32fe1611a4b6da25805ae924c7c26
20 Nca563e31a0004e4aa67913792a22c859
21 Nd0c2651f4eb845bcb875439b975b613e
22 Nd5d228cb760140e283302695dc01beb1
23 anzsrc-for:11
24 anzsrc-for:1112
25 schema:author N3fe72b8939f6497fbbe3328fd114b5ef
26 schema:citation sg:pub.10.1007/s001090050233
27 sg:pub.10.1038/sj.bjc.6690494
28 schema:datePublished 2000-11
29 schema:datePublishedReg 2000-11-01
30 schema:description A new concept of classifying neuroendocrine pancreatic tumors based on clinicopathologic patterns was summarized recently. To evaluate the clinical reliability and prognostic specificity of this classification system, 100 neuroendocrine pancreatic tumors were retrospectively categorized as “benign,”“uncertain,” and “malignant” based on tumor risk factors (size, local invasion and angioinvasion, cell atypia, metastases) and were followed for disease recurrence and progression. Altogether, 71 functioning tumors (insulinoma, gastrinoma, glucagonoma, enterochromaffin-like (ECL)oma, somatostatinoma) and 29 nonfunctioning neuroendocrine pancreatic tumors (NETs) were studied. NETs had an increased risk of malignancy (p < 0.05). Tumor size, gross invasion, and metastases correlated significantly with tumor behavior and allowed us to distinguish between “benign” and “malignant” tumors. About 89% of the tumors ≤ 20 mm were “benign,” whereas 71% > 20 mm were “malignant” (p < 0.05). In patients with “benign” and “uncertain” neuroendocrine pancreatic tumors, neither recurrence nor progression of disease was seen. About 41% of the patients with “malignant” tumors died of the disease. The 5-year estimated cumulative survival of those with “benign” and “uncertain” tumors was 100% and 52 ± 10% for those with “malignant” tumors (p < 0.05). Histomorphologic details classifying the behavior of an “uncertain” tumor are known only after initial treatment and definitive histopathologic investigation. Thus this information is of limited clinical help for treatment strategies.
31 schema:genre article
32 schema:inLanguage en
33 schema:isAccessibleForFree false
34 schema:isPartOf N50c0074aba174f6498c5d09a60867d37
35 N8e270ced8bb0436f8c68bf7a412040df
36 sg:journal.1086446
37 schema:keywords NETs
38 behavior
39 classification
40 classification system
41 clinical help
42 clinical reliability
43 clinicopathologic patterns
44 concept
45 cumulative survival
46 definitive histopathologic investigation
47 detail
48 disease
49 disease recurrence
50 factors
51 gross invasion
52 help
53 histomorphologic detail
54 histopathologic investigation
55 information
56 initial treatment
57 invasion
58 investigation
59 limited clinical help
60 malignancy
61 metastasis
62 neuroendocrine pancreatic tumors
63 new classification
64 new concept
65 pancreatic tumors
66 patients
67 patterns
68 prognostic specificity
69 progression
70 progression of disease
71 recurrence
72 reliability
73 risk
74 risk factors
75 risk of malignancy
76 size
77 specificity
78 strategies
79 survival
80 system
81 treatment
82 treatment strategies
83 tumor behavior
84 tumor risk factors
85 tumor size
86 tumors
87 schema:name Is the New Classification of Neuroendocrine Pancreatic Tumors of Clinical Help?
88 schema:pagination 1312-1318
89 schema:productId Nacdd1ecda7694dec84efe115a95306c2
90 Nd6883dbef18347a581e724650602c5fc
91 Ne5ba2478f5ea4cdd85339cc1ecd71e72
92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034826001
93 https://doi.org/10.1007/s002680010217
94 schema:sdDatePublished 2021-12-01T19:12
95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
96 schema:sdPublisher N5e461a9bf0534eae8ec3c920b7e83f08
97 schema:url https://doi.org/10.1007/s002680010217
98 sgo:license sg:explorer/license/
99 sgo:sdDataset articles
100 rdf:type schema:ScholarlyArticle
101 N020871f77f4c47469b0a31f6d333e0af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Humans
103 rdf:type schema:DefinedTerm
104 N0fed3f9ef25c4fc8a30a0c23a1ed7c8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Evaluation Studies as Topic
106 rdf:type schema:DefinedTerm
107 N1fd455226c99403488c06549efc75e81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Pancreatectomy
109 rdf:type schema:DefinedTerm
110 N24825158f98f45a191bec1017f867bc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Child
112 rdf:type schema:DefinedTerm
113 N289fbca686b8463db3d622b6587d6f7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Reproducibility of Results
115 rdf:type schema:DefinedTerm
116 N2c0dc2c07ad64ea98d3a6a85b3b2de3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Retrospective Studies
118 rdf:type schema:DefinedTerm
119 N2ccde197aa094eaba9fec4dfae27d560 rdf:first sg:person.014465706030.17
120 rdf:rest rdf:nil
121 N315f73f1012f42ceaf69f8311e187a97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Neuroendocrine Tumors
123 rdf:type schema:DefinedTerm
124 N36402be6fe2544f0981f6636af20fbe8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Pancreatic Neoplasms
126 rdf:type schema:DefinedTerm
127 N3fe72b8939f6497fbbe3328fd114b5ef rdf:first sg:person.0603017413.32
128 rdf:rest Nd321612bbc4148c098c996362a114019
129 N445c6bdc136747a48ce0e87b7817b852 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Male
131 rdf:type schema:DefinedTerm
132 N50c0074aba174f6498c5d09a60867d37 schema:issueNumber 11
133 rdf:type schema:PublicationIssue
134 N5a6078a30f6d4978aad489e4987b9e80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Aged, 80 and over
136 rdf:type schema:DefinedTerm
137 N5de8bcee78b847468f58633362be2e62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Female
139 rdf:type schema:DefinedTerm
140 N5e461a9bf0534eae8ec3c920b7e83f08 schema:name Springer Nature - SN SciGraph project
141 rdf:type schema:Organization
142 N6d73bd534ea64c36be331db2089ef97e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Follow-Up Studies
144 rdf:type schema:DefinedTerm
145 N8e270ced8bb0436f8c68bf7a412040df schema:volumeNumber 24
146 rdf:type schema:PublicationVolume
147 N908c353cefd44d70a6dfdbb59b16b64e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Neoplasm Staging
149 rdf:type schema:DefinedTerm
150 N9f721c435f9d4a098f72618dff93404e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Disease-Free Survival
152 rdf:type schema:DefinedTerm
153 Na2df85fda9634445aac5079398577463 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Sensitivity and Specificity
155 rdf:type schema:DefinedTerm
156 Na4e7003b24b64f42a7a7447353833785 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Adult
158 rdf:type schema:DefinedTerm
159 Nacdd1ecda7694dec84efe115a95306c2 schema:name pubmed_id
160 schema:value 11038199
161 rdf:type schema:PropertyValue
162 Nae8e8a308b744f5dbbd6672573002802 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Aged
164 rdf:type schema:DefinedTerm
165 Nafa6ce549a804f4daf5458a8b02ae712 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Survival Rate
167 rdf:type schema:DefinedTerm
168 Nbbf32fe1611a4b6da25805ae924c7c26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Biopsy, Needle
170 rdf:type schema:DefinedTerm
171 Nca4b721c2fa04a0bb9a3fa09b33d3193 rdf:first sg:person.01046040764.07
172 rdf:rest N2ccde197aa094eaba9fec4dfae27d560
173 Nca563e31a0004e4aa67913792a22c859 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Middle Aged
175 rdf:type schema:DefinedTerm
176 Nd0c2651f4eb845bcb875439b975b613e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Adolescent
178 rdf:type schema:DefinedTerm
179 Nd321612bbc4148c098c996362a114019 rdf:first sg:person.01163404744.70
180 rdf:rest Nca4b721c2fa04a0bb9a3fa09b33d3193
181 Nd5d228cb760140e283302695dc01beb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Pancreatic Function Tests
183 rdf:type schema:DefinedTerm
184 Nd6883dbef18347a581e724650602c5fc schema:name doi
185 schema:value 10.1007/s002680010217
186 rdf:type schema:PropertyValue
187 Ne5ba2478f5ea4cdd85339cc1ecd71e72 schema:name dimensions_id
188 schema:value pub.1034826001
189 rdf:type schema:PropertyValue
190 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
191 schema:name Medical and Health Sciences
192 rdf:type schema:DefinedTerm
193 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
194 schema:name Oncology and Carcinogenesis
195 rdf:type schema:DefinedTerm
196 sg:journal.1086446 schema:issn 0364-2313
197 1432-2323
198 schema:name World Journal of Surgery
199 schema:publisher Springer Nature
200 rdf:type schema:Periodical
201 sg:person.01046040764.07 schema:affiliation grid-institutes:grid.22937.3d
202 schema:familyName Kaserer
203 schema:givenName Klaus
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046040764.07
205 rdf:type schema:Person
206 sg:person.01163404744.70 schema:affiliation grid-institutes:grid.22937.3d
207 schema:familyName Kaczirek
208 schema:givenName Klaus
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163404744.70
210 rdf:type schema:Person
211 sg:person.014465706030.17 schema:affiliation grid-institutes:grid.22937.3d
212 schema:familyName Niederle
213 schema:givenName Bruno
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014465706030.17
215 rdf:type schema:Person
216 sg:person.0603017413.32 schema:affiliation grid-institutes:grid.22937.3d
217 schema:familyName Schindl
218 schema:givenName Martin
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603017413.32
220 rdf:type schema:Person
221 sg:pub.10.1007/s001090050233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014446718
222 https://doi.org/10.1007/s001090050233
223 rdf:type schema:CreativeWork
224 sg:pub.10.1038/sj.bjc.6690494 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039860600
225 https://doi.org/10.1038/sj.bjc.6690494
226 rdf:type schema:CreativeWork
227 grid-institutes:grid.22937.3d schema:alternateName Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, Währinger Gürtel 18-20, A 1090 Vienna, Austria, AT
228 Institute of Clinical Pathology, University of Vienna Medical School, Währinger Gürtel 18-20, A 1090 Vienna, Austria, AT
229 schema:name Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, Währinger Gürtel 18-20, A 1090 Vienna, Austria, AT
230 Institute of Clinical Pathology, University of Vienna Medical School, Währinger Gürtel 18-20, A 1090 Vienna, Austria, AT
231 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...